Form 4/A for FATE FATE THERAPEUTICS INC
Accepted 2022-06-08 00:00:00 ET · period of report 2022-06-03 · accession 0001209191-22-034992 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-06-08 | 2022-06-03 | FATE | Agarwal Shefali | Dir | S - Sale | — | 0 | 2,681 | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-03 | S | D | 0 | $0.00 | 2,681 | D | — | — | (F1) Corrected to reflect that no shares were sold on June 3, 2022. |